Working closely with the Hemanext team, we crafted medical animations to elucidate the science behind oxidative damage in stored blood. To leverage the visuals for multiple communication needs, the content was broken into chapters.
XVIVO and Forma partnered together for multiple medical animation projects to educate both healthcare professionals and patients on their scientific approach. Sickle cell disease is an inherited genetic disease that has serious impacts on the people living with it. Forma Therapeutics is fiercely dedicated to improving the lives of these patients.
In collaboration with Global Blood Therapeutics, our folks here at XVIVO created this medical animation to illustrate the mechanism of action of a potential drug candidate for the treatment of sickle cell disease (SCD).
The animation, developed in partnership with Wedgewood Communications, shows the mechanism of disease for IPF and the mechanism of action for the recently-approved agent OFEV (nintedanib) from Boehringer Ingelheim.
Whether it is presenting your work at trade shows, capturing the attention of a busy physician, or educating your patients, let XVIVO help your story stand out from the rest with active experiences that educate, excite, and inspire your audiences.
In collaboration with Global Blood Therapeutics, our folks here at XVIVO created this medical animation …
About 50,000 people in the United States are diagnosed with IPF each year. After diagnosis, …